Allelic loss at TP53 in metastatic human endometrial carcinomas

Clinical and Experimental Metastasis

Volumn 26, Issue 7, 2009, Pages 789-796

  Szewczuk, Wiktor ^a   Skomra, Danuta ^a   Cybulski, Marek ^a   Prządka Rabaniuk, Dorota ^a   Filip, Agata ^a   Jóźwik, Maciej ^b   Olcha, Piotr ^a   Roessner, Albert ^c   Semczuk, Andrzej ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Endometrial cancer; Immunohistochemistry; LOH; Metastasis; TP53

Indexed keywords

PROTEIN P53;

ADULT; ADVANCED CANCER; AGED; ALLELIC IMBALANCE; ARTICLE; CLINICAL ARTICLE; EARLY CANCER; ENDOMETRIUM CARCINOMA; EXON; FEMALE; GENE OVEREXPRESSION; GENETIC POLYMORPHISM; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; INCIDENCE; INTRON; METASTASIS; TP53 GENE; TUMOR SUPPRESSOR GENE; UTERINE TUBE;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ENDOMETRIAL NEOPLASMS; FEMALE; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; INTRONS; LOSS OF HETEROZYGOSITY; MIDDLE AGED; NEOPLASM METASTASIS;

EID: 71849091530     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-009-9278-3     Document Type: Article

References (40)

1. AB De Leo G Jay E Appella GC Dubois LW Law LJ Old 1979 Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse Proc Natl Acad Sci USA 76 2420 2424 10.1073/pnas.76.5.2420 (Pubitemid 9185501)
2. DP Lane 1992 p53, guardian of the genome Nature 358 15 16 10.1038/358015a0 1614522
3. B Vogelstein D Lane AJ Levine 2000 Surfing the p53 network Nature 408 307 310 10.1038/35042675 11099028
4. JC Bourdon 2007 p53 and its isoforms in cancer Br J Cancer 97 277 282 10.1038/sj.bjc.6603886 17637683 (Pubitemid 47196755)
5. EE Balint KH Vousden 2001 Activation and activities of the p53 tumor suppressor protein Br J Cancer 85 1813 1823 10.1054/bjoc.2001.2128
6. D Lane 2004 p53 from pathway to therapy. Anthony Dipple Carcinogenesis Award Carcinogenesis 25 1077 1081 10.1093/carcin/bgh186 15205365 (Pubitemid 38968035)
7. SL Harris AJ Levine 2005 The p53 pathway: positive and negative feedback loops Oncogene 24 2899 2908 10.1038/sj.onc.1208615 15838523 (Pubitemid 40638098)
8. DP Guimaraes P Hainaut 2002 TP53: a key gene in human cancer Biochimie 84 83 93 10.1016/S0300-9084(01)01356-6 11900880 (Pubitemid 34477096)
9. T Soussi 2007 p53 alterations in human cancer: more questions than answers Oncogene 26 2145 2156 10.1038/sj.onc.1210280 17401423 (Pubitemid 46536642)
10. A Petitjean MI Achatz AL Borresen-Dale P Hainaut M Olivier 2007 TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes Oncogene 26 2157 2165 10.1038/sj.onc.1210302 17401424 (Pubitemid 46536647)
11. A Velasco J Pallares M Santacana A Yeramian X Dolcet N Eritja S Puente A Sorolla N Llecha X Matias-Guiu 2008 Loss of heterozygosity in endometrial carcinoma Int J Gynecol Pathol 27 305 317 10.1097/PGP.0b013e31815daf1a 18580307
12. A Semczuk B Marzec A Roessner JA Jakowicki J Wojcierowski R Schneider-Stock 2002 Loss of heterozygosity of the retinoblastoma gene is correlated with the altered pRb expression in human endometrial cancer Virchows Arch 441 577 583 10.1007/s00428-002-0695-9 12461615 (Pubitemid 35435828)
13. SX Liang SK Chambers L Cheng S Zhang Y Zhou W Zheng 2004 Endometrial glandular dysplasia: a putative precursor lesion of uterine papillary serous carcinoma. Part II: molecular features Int J Surg Pathol 12 319 331 10.1177/106689690401200405 15494858 (Pubitemid 39463501)
14. O Graesslin S Chantot-Bastaraud M Lorenzato P Birembaut C Quereux E Darai 2008 Fluorescence in situ hybridization and immunohistochemical analysis of p53 expression in endometrial cancer: prognostic value and relation to ploidy Ann Surg Oncol 15 484 492 10.1245/s10434-007-9712-1 18071824
15. A Semczuk B Marzec D Skomra A Roessner M Cybulski T Rechberger R Schneider-Stock 2005 Allelic loss at TP53 is not related to p53 protein overexpression in primary human endometrial carcinomas Oncology 69 317 325 10.1159/000089764 16293976 (Pubitemid 41752800)
16. World Health Organisation Classification of Tumours. Pathology and genetics of tumors of the breast and female genital organs (2003) Tavassoli FA, Devilee P (ed.), IACR Press, Lyon
17. JJ Mikuta 1995 Preoperative evaluation and staging of endometrial cancer Cancer 76 10 suppl. 2041 2043 10.1002/1097-0142(19951115)76:10+<2041::AID- CNCR2820761322>3.0.CO;2-Z 8634997
18. M Hahn J Serth R Fislage H Wolfes E Allhoff V Jonas A Pingoud 1993 Polymerase chain reaction detection of a highly-polymorphic VNTR segment in intron 1 of the human p53 gene Clin Chem 39 549 550 8448878
19. MH Jones Y Nakamura 1992 Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism Genes Chromosomes Cancer 5 89 90 10.1002/gcc.2870050113 1384667
20. O de la Calle-Martin V Fabregat M Romero J Soler J Vives J Yague 1990 AccII polymorphism of the p53 gene Nucleic Acids Res 18 4963
21. A Alkushi P Lim A Coldman D Huntsman D Miller CB Gilks 2004 Interpretation of p53 immunoreactivity in endometrial carcinoma: establishing a clinically relevant cut-off level Int J Gynecol Pathol 23 129 137 10.1097/00004347-200404000-00007 15084841 (Pubitemid 38391772)
22. D Lasko W Cavenee M Nordenskjold 1991 Loss of constitutional heterozygosity in human cancer Annu Rev Genet 25 281 314 10.1146/annurev.ge.25. 120191.001433 1687498
23. B Ponder 1998 Gene losses in human tumours Nature 335 400 402 10.1038/335400a0
24. S Knuutila Y Aalto K Autio AM Bjorkqvist W El-Rifai S Hemmer T Huhta E Kettunen S Kiuru-Kuhlefelt ML Larramendy T Lushnikova O Monni H Pere J Tapper M Tarkkanen A Varis VM Wasenius M Wolf Y Zhu 1999 DNA copy number losses in human neoplasms Am J Pathol 155 683 694 10487825 (Pubitemid 29426813)
25. AG Knudson Jr 1971 Mutation and cancer: statistical study of retinoblastoma Proc Natl Acad Sci USA 68 820 823 10.1073/pnas.68.4.820 5279523
26. MH Jones S Koi I Fujimoto K Hasumi K Kato Y Nakamura 1994 Allelotype of uterine cancer by analysis of RFLP and microsatellite polymorphisms: frequent loss of heterozygosity on chromosome arms 3p, 9q, 10q, and 17p Genes Chrom Cancer 9 119 123 10.1002/gcc.2870090207 7513541
27. X Li NK Lee YW Ye PG Waber C Schweitzer QC Cheng PD Nisen 1994 Allelic loss at chromosomes 3p, 8p, 13q, and 17p associated with poor prognosis in head and neck cancer J Natl Cancer Inst 86 1524 1529 10.1093/jnci/86.20.1524 7932807
28. J-C Bourdon K Fernandes F Murray-Zmijewski G Liu A Diot DP Xirodimas MK Saville DP Lane 2005 p53 isoforms can regulate p53 transcriptional activity Genes Dev 19 2122 2137 10.1101/gad.1339905 16131611 (Pubitemid 41330315)
29. I Heide C Thiede T Sonntag E de Kant A Neubauer S Jonas FJ Peter P Neuhaus R Herrmann D Huhn CF Rochlitz 1997 The status of p53 in the metastatic progression of colorectal cancer Eur J Cancer 33 1314 1322 10.1016/S0959- 8049(97)00118-4 9301461 (Pubitemid 27362779)
30. RN Baergen CD Warren C Isacson LH Ellenson 2001 Early uterine serous carcinoma: clonal origin of extrauterine disease Int J Gynecol Pathol 20 214 219 10.1097/00004347-200107000-00002 11444195
31. J Kupryjanczyk AD Thor R Beauchamp C Poremba RE Scully DW Yandell 1996 Ovarian, peritoneal, and endometrial serous carcinoma: clonal origin of multifocal disease Mod Pathol 9 166 173 8685209
32. T Kihana K Hamada Y Inoue N Yano H Iketani S Murao M Ukita S Matsuura 1995 Mutation and allelic loss of the p53 gene in endometrial carcinoma. Incidence and outcome in 92 surgical patients Cancer 76 72 78 10.1002/1097-0142(19950701)76:1<72::AID-CNCR2820760110>3.0.CO;2-3 8630879
33. D Niederacher HX An S Camrath SI Dominik UJ Gohring A Oertel M Grass P Hantschmann MR Lordnejad MW Beckmann 1998 Loss of heterozygosity of BRCA1, TP53 and TCRD markers analysed in sporadic endometrial cancer Eur J Cancer 34 1770 1776 10.1016/S0959-8049(98)00270-6 9893667 (Pubitemid 28474234)
34. M Saegusa I Okayasu 1997 Bcl-2 is closely correlated with favorable prognostic factors and inversely associated with p53 protein accumulation in endometrial carcinomas: immunohistochemical and polymerase chain reaction/loss of heterozygosity findings J Cancer Res Clin Oncol 123 429 434 10.1007/BF01372546 9292705
35. S-H Liang MF Clarke 2001 Regulation of p53 localization Eur J Biochem 268 2779 2783 10.1046/j.1432-1327.2001.02227.x 11358492 (Pubitemid 32862959)
36. R Jeczen D Skomra M Cybulski R Schneider-Stock W Szewczuk A Roessner T Rechberger A Semczuk 2007 P53/MDM2 overexpression in metastatic endometrial cancer: correlation with clinicopathological features and patient outcome Clin Exp Metastasis 24 503 511 10.1007/s10585-007-9087-5 17671841 (Pubitemid 47524808)
37. M Inoue 2001 Current molecular aspects of the carcinogenesis of the uterine endometrium Int J Gynecol Cancer 11 339 348 10.1046/j.1525-1438.2001. 01046.x 11737463 (Pubitemid 33021134)
38. HB Salvesen LA Akslen 2002 Molecular pathogenesis and prognostic factors in endometrial carcinoma APMIS 110 673 689 10.1034/j.1600-0463.2002.1101001.x 12583434 (Pubitemid 36005834)
39. J Prat 2004 Prognostic parameters of endometrial carcinoma Hum Pathol 35 649 662 10.1016/j.humpath.2004.02.007 15188130 (Pubitemid 38881074)
40. A Doll M Abal M Rigau M Monge M Gonzalez S Demajo E Colas M Llaurado H Alazzouzi J Planaguma MA Lohmann J Garcia S Castellvi J Ramon y Cajal A Gil-Moreno J Xercavins F Alameda J Reventos 2008 Novel molecular profiles of endometrial cancer-new light through old windows J Steroid Biochem Mol Biol 108 221 229 10.1016/j.jsbmb.2007.09.020 18061438 (Pubitemid 351179637)